CORRECTION article

Front. Psychiatry, 16 February 2024

Sec. Anxiety and Stress Disorders

Volume 15 - 2024 | https://doi.org/10.3389/fpsyt.2024.1372373

Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings

  • 1. Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States

  • 2. Department of Psychology, Yale University, New Haven, CT, United States

  • 3. Center for Brain and Mind Health, Yale University School of Medicine, New Haven, CT, United States

  • 4. Child Study Center, Yale University School of Medicine, New Haven, CT, United States

Article metrics

View details

1,9k

Views

547

Downloads

Error in Author List

In the published article, there was an error in the author list, and Anastasia Jankovsky was erroneously excluded. The corrected author list appears below.

Terence H. W. Ching,1 Lucia Amoroso,1 Calvin Bohner,1 Elizabeth D'Amico,1 Jeffrey Eilbott,1 Tara Entezar,1 Madison Fitzpatrick,1 Geena Fram,1 Rachael Grazioplene,1 Jamila Hokanson,1 Anastasia Jankovsky,1 Stephen A. Kichuk,1 Bradford Martins,1 Prerana Patel,1 Henry Schaer,1 Sarah Shnayder,1 Chelsea Witherow,1 Christopher Pittenger,1-4 Benjamin Kelmendi1

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

obsessive-compulsive disorder, psilocybin, psychedelic, non-directive support, waitlist, treatment, mental health, adult psychiatry

Citation

Ching THW, Amoroso L, Bohner C, D'Amico E, Eilbott J, Entezar T, Fitzpatrick M, Fram G, Grazioplene R, Hokanson J, Jankovsky A, Kichuk SA, Martins B, Patel P, Schaer H, Shnayder S, Witherow C, Pittenger C and Kelmendi B (2024) Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings. Front. Psychiatry 15:1372373. doi: 10.3389/fpsyt.2024.1372373

Received

17 January 2024

Accepted

01 February 2024

Published

16 February 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Terence H. W. Ching,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics